RE:RE:RE:Message to Shareholders, November 2022Appears real investors agree, leaving the MPH share price where it was prior to the announcement. Comparing first 9 months of 2021 Vs 2022 not relevant. Have to look at quarter to quarter growth...and that is not happening in any significant way. MPH outsources its manufacturing, the generics will do it in house so can easily undercut...and at the end of the day, if MPH is not worried, why did they spend millions defending a patent challenge a couple of years ago that settled with the Company getting early entrance....around now in fact.